These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6108382)

  • 1. [Pathogenetic therapy of cobalt-induced cardiomyopathies].
    Chekunova MP; Suvorov IM; Zenkevich ES; Chekodanova NV; Minkina NA
    Kardiologiia; 1980 Nov; 20(11):60-4. PubMed ID: 6108382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nandrolone decanoate reduces the premature mortality of cardiomyopathic hamsters.
    Davis WM; Long SF; Lin TL
    Res Commun Chem Pathol Pharmacol; 1993 Jul; 81(1):21-32. PubMed ID: 8210687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenetic therapy procedures in cobalt lesions of the myocardium].
    Chekunova MP; Minkina NA; Suvorov IM
    Gig Tr Prof Zabol; 1978 Dec; (12):50-2. PubMed ID: 363535
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive treatment of ischemic heart disease with obsidan and nerobolil under ambulatory conditions].
    Ianovskiĭ GV; Shevchuk SG; Girina NI; Petrusha GN
    Vrach Delo; 1978 Jun; (6):16-8. PubMed ID: 695461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanisms of the retabolil restoration of liver functions in a toxic lesion from tetrachloromethane].
    Sinitsyn PD; Riabinina NE
    Gig Tr Prof Zabol; 1981 Aug; (8):35-7. PubMed ID: 7286713
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anabolic drugs in biochemical myocardial damages].
    Kutschera-Aichbergen H
    Wien Med Wochenschr; 1966 Apr; 116(16):352-4. PubMed ID: 5985191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phonomecanographic study of 3 beta-blockers and d-propranolol in obstructive cardiomyopathy].
    Hitchitz S; Veyrat C; Gourtchiglouian M
    Therapie; 1978; 33(5):599-606. PubMed ID: 33466
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic cardiomyopathies.
    Balazs T; Herman EH
    Ann Clin Lab Sci; 1976; 6(6):467-76. PubMed ID: 793502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
    Girina NI
    Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of beta-receptor blockaders in hypertrophic obstructive cardiomyopathy (HOCM)].
    Kuhn H; Loogen F
    Internist (Berl); 1978 Sep; 19(9):527-31. PubMed ID: 29851
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic blockade in the treatment of left-sided hypertrophic obstructive cardiomyopathy (HOCM).
    Rookmaker WA; Nieveen J; Kruizinga K; Blickman JR
    Acta Med Scand; 1971 May; 189(5):427-31. PubMed ID: 4397077
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-blockade in adriamycin-induced cardiomyopathy.
    Noori A; Lindenfeld J; Wolfel E; Ferguson D; Bristow MR; Lowes BD
    J Card Fail; 2000 Jun; 6(2):115-9. PubMed ID: 10908085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effect of propranolol from alcohol-induced heart muscle damage as assessed by plasma cardiac troponin-t.
    Patel VB; Ajmal R; Sherwood RA; Sullivan A; Richardson PJ; Preedy VR
    Alcohol Clin Exp Res; 2001 Jun; 25(6):882-9. PubMed ID: 11410725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-adrenergic blocking agents ATP and anabolic hormones in the treatment of ischemic heart disease].
    Smolenskiĭ VS; Abinder AA
    Sov Med; 1977 Jan; (1):44-8. PubMed ID: 15321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta-mimetic and anabolic drugs in the therapy of experimental placental lesions].
    Garzetti GG; Masini L; Riccardi P; Guariglia L; Serri FG; Bellati U
    Ann Ostet Ginecol Med Perinat; 1980; 101(4):244-8. PubMed ID: 6113809
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.
    Guillory AN; Herndon DN; Silva MB; Andersen CR; Suman OE; Finnerty CC
    J Burn Care Res; 2017; 38(4):243-250. PubMed ID: 28240622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should beta adrenergic blocking drugs be used in congestive cardiomyopathy?
    Reddy KS; Bhatia ML
    Indian J Chest Dis Allied Sci; 1983; 25():49-53. PubMed ID: 6137453
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morphological criteria of the effectiveness of nitroglycerin, dipyridamole and propranolol hydrochloride in an experimental metabolic lesion of the myocardium].
    Gichka SG
    Vrach Delo; 1984 Jul; (7):55-7. PubMed ID: 6433559
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic blocking agents in hypertrophic cardiomyopathy (HOCM).
    Oakley CM
    Singapore Med J; 1973 Sep; 14(3):408-9. PubMed ID: 4149721
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of action of dimethyl quaternary propranolol (UM-272) in isoproterenol-induced cardiomyopathy in rats.
    Gupta M; Seth SD; Gupta MP; Manchanda SC
    Indian J Med Res; 1983 Jun; 77():886-94. PubMed ID: 6642587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.